Blog

What is X-Linked Agammaglobulinemia? What happens when the body can’t make the antibodies it needs to fight infections? X-linked agammaglobulinemia (XLA) is a rare genetic condition that affects about 1 in 200,000 male births.  In this condition, a mutation in one of the genes for B cells—which are critical immune cells—prevents your immune system from functioning properly. This leaves your body without the antibodies it needs to fight off bacteria effectively. The gene is called the BTK (Bruton’s Tyrosine Kinase) gene. Boys with XLA often start showing symptoms in early childhood, including frequent ear infections, pneumonia, and sinus problems. Because their immune systems can’t “remember” past infections, these children are

What to Consider When Choosing a Site of Care Site of care selection is a critical component in improving outcomes and managing total cost of care. Whether delivering biologics, specialty injectables, or infusion therapies, the setting matters—clinically, operationally, and financially. Moving appropriate therapies from high-cost hospital settings to home or ambulatory infusion centers may reduce costs, support adherence, and maintain consistent quality. With the right partners and infrastructure, alternate sites of care support personalized, guideline-driven treatment while easing pressure on health systems and streamlining patient access. What Does ‘Site of Care’ Mean? The term “site of care” might sound clinical, but it’s simply the physical location where medical treatments are

How Biosimilar Cost Savings Benefit Health Systems Biosimilars offer a compelling opportunity for healthcare organizations to manage rising costs while maintaining high-quality care. These therapies, comparable to already approved biologic drugs, can generate significant cost savings without compromising clinical outcomes. The most direct financial impact is often felt by patients and payors, with lower out-of-pocket costs and reduced therapy expenditures. At the same time, health systems and providers benefit from the clinical value—biosimilars deliver outcomes with no clinical difference as compared to reference biologics, ensuring that care quality is not compromised.  For decision-makers, understanding the role of biosimilars is essential. Their adoption can help optimize therapy access, strengthen formulary management,

The Benefits of a Patient Adherence Program For Healthcare Providers Medication adherence is a persistent challenge in specialty care. Complex dosing schedules, therapy side effects, and the high cost of specialty medications may prevent patients from following prescribed treatment plans, impacting both clinical outcomes and the cost of care. A structured adherence program addresses these challenges directly. By providing end-to-end support, including financial navigation, therapy monitoring, and side-effect management, these programs help maintain treatment continuity and improve overall effectiveness. For providers, payors, and health systems, the value is clear: stronger clinical outcomes, reduced avoidable hospitalizations, and enhanced alignment across the care continuum. The Challenge of Medication Adherence in Specialty Medication

How to Streamline the Pharmacy Claims Processing Workflow in Specialty Care Navigating pharmacy claims in specialty care is far from straightforward. For healthcare providers, payors, and health systems, every prescription represents not just a treatment plan but a series of coordinated steps that must align perfectly to ensure timely therapy delivery. Even small errors—missing documentation, coverage misunderstandings, or delays in prior authorizations—can cascade into longer treatment start times and frustrated patients. A well-structured pharmacy claims processing workflow isn’t just a procedural necessity—it’s a critical component of delivering high-quality care. Streamlined workflows reduce friction, minimize errors, and create predictability for both patients and providers. For specialty therapies, where medications are high-cost,

How to Optimize the Benefit Investigation Process to Support Patient Access and Costs Benefit investigation is a critical process for specialty therapies, providing clarity on insurance coverage and reimbursement requirements. By identifying coverage details upfront, providers and payors can reduce delays, anticipate potential costs, and ensure timely access to therapies. This process supports both operational efficiency and financial predictability. Accurate benefit investigation enables care teams to plan therapy delivery, coordinate prior authorizations, and manage site-of-care decisions with confidence. It also helps safeguard high-quality care by ensuring patients receive appropriate therapies without avoidable interruptions. By integrating benefit investigation into specialty pharmacy workflows, healthcare organizations gain seamless, end-to-end support. Transparent communication, efficient